CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Connaughton Bernadette Director | Sale 10b5-1 | −1,626 | $102.80 | $167K | 40,418 |
| 2026-07-08 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +1,923 | $12.07 | $23K | 769,703 |
| 2026-07-08 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −888 | $79.28 | $70K | 768,815 |
| 2026-07-08 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −1,035 | $80.19 | $83K | 767,780 |
| 2026-07-08 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −1,923 | $12.07 | $23K | 0 |
| 2026-07-01 | RAMSAY DAVID A EVP, PRESIDENT, DRUG DELIVERY | Grant or award · Restricted Stock Units | +16,232 | 16,232 | ||
| 2026-07-01 | RAMSAY DAVID A EVP, PRESIDENT, DRUG DELIVERY | Grant or award · Option to Purchase Common Stock | +39,823 | 39,823 | ||
| 2026-07-01 | Snellgrove Darren SVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +41,554 | 41,554 | ||
| 2026-07-01 | Snellgrove Darren SVP, Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +127,432 | 127,432 | ||
| 2026-07-01 | Connaughton Bernadette Director | Sale 10b5-1 | −1,000 | $76.40 | $76K | 42,669 |
| 2026-07-01 | Connaughton Bernadette Director | Sale 10b5-1 | −625 | $77.21 | $48K | 42,044 |
| 2026-06-30 | RAMSAY DAVID A EVP, PRESIDENT, DRUG DELIVERY | Option exercise | +10,000 | 10,000 | ||
| 2026-06-30 | RAMSAY DAVID A EVP, PRESIDENT, DRUG DELIVERY | Shares withheld for taxes | −5,408 | $78.27 | $423K | 4,592 |
| 2026-06-30 | RAMSAY DAVID A EVP, PRESIDENT, DRUG DELIVERY | Option exercise · Restricted Stock Units | −10,000 | 0 | ||
| 2026-06-29 | Krishnan Mahesh Director | Option exercise 10b5-1 | +7,304 | $38.46 | $281K | 21,766 |
| 2026-06-29 | Krishnan Mahesh Director | Sale 10b5-1 | −7,304 | $75.00 | $548K | 14,462 |
| 2026-06-29 | Krishnan Mahesh Director | Option exercise · Option to Purchase Common Stock 10b5-1 | −7,304 | 1,500 | ||
| 2026-06-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise | +5,034 | 52,644 | ||
| 2026-06-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Shares withheld for taxes | −2,715 | $69.50 | $189K | 49,929 |
| 2026-06-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Units | −5,034 | 10,068 |
Page 4 of 26 · 513 trades